{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:26:28Z","timestamp":1786987588299,"version":"build-2736575974"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":121,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.100938","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:51:34Z","timestamp":1746726694000},"page":"100938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A systemic review on chemotherapy induced nausea and vomiting- risk and clinical management with alternative therapies"],"prefix":"10.1016","volume":"44","author":[{"given":"Derangula","family":"Lavanya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VelugotlaPranathi","family":"Prasanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Firdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-1702","authenticated-orcid":false,"given":"Sneha","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2025.100938_bib0001","doi-asserted-by":"crossref","unstructured":"Yolanda Escobar, Gerardo Cajaraville, Juan Antonio Virizuela, Rosa \u00c1lvarez1 et al.(2015): Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study. DOI 10.1007\/s00520-015-2809-3.","DOI":"10.1007\/s00520-015-2809-3"},{"key":"10.1016\/j.ctarc.2025.100938_bib0002","series-title":"Cancer: principles and practice of oncology","first-page":"2705","article-title":"Adverse effects of treatment, nausea and vomiting","author":"Berger","year":"1997"},{"key":"10.1016\/j.ctarc.2025.100938_bib0003","first-page":"3141","article-title":"Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients\u2019 quality of life","volume":"20","author":"Fern\u00e1ndez-Ortega","year":"2012","journal-title":"Supp. Care Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0004","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","article-title":"Delayed nausea and vomiting continue to reduce patients\u2019 quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment","volume":"24","author":"Bloechl-Daum","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0005","series-title":"Supportive care in cancer","author":"Klastersky","year":"1999"},{"key":"10.1016\/j.ctarc.2025.100938_bib0006","first-page":"307","article-title":"Effect of post chemotherapy nausea and vomiting on health-related quality of life. The quality of life and symptom control committees of the National Cancer Institute of Canada clinical trials group","volume":"5","author":"Osoba","year":"1997","journal-title":"Supp. Care Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/07357900009038248","article-title":"Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapyinduced nausea and vomiting","volume":"18","author":"Hesketh","year":"2000","journal-title":"Cancer Invest."},{"key":"10.1016\/j.ctarc.2025.100938_bib0008","first-page":"35","article-title":"Patterns of nausea, vomiting, and distress in patients receiving antineoplastic drug protocols","volume":"14","author":"Rhodes","year":"1987","journal-title":"Oncol. Nurs. Forum."},{"key":"10.1016\/j.ctarc.2025.100938_bib0009","first-page":"232","article-title":"Nausea, vomiting, and retching: complex problems in palliative care","volume":"51","author":"Rhodes","year":"2001","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100938_bib0010","article-title":"PharmD, BCPS, BCOP.Chemotherapy-induced nausea and vomiting","volume":"14","author":"Lisa","year":"2008","journal-title":"Cancer J."},{"issue":"10","key":"10.1016\/j.ctarc.2025.100938_bib0018","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","article-title":"Incidence of chemotherapy-induced nausea and emesis after modern antiemetics","volume":"100","author":"Grunberg","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0019","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2013.10.015","article-title":"Prognostic factors for chemotherapy induced nausea and vomiting","volume":"722","author":"Warr","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100938_bib0020","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/annonc\/mdx100","article-title":"The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting","volume":"28","author":"Dranitsaris","year":"2017","journal-title":"Ann. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.ctarc.2025.100938_bib0021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000227643","article-title":"Control of acute cisplatin-induced emesis over repeat courses of chemotherapy. Italian Group for Antiemetic Research","volume":"53","author":"Roila","year":"1996","journal-title":"Oncology"},{"issue":"11","key":"10.1016\/j.ctarc.2025.100938_bib0022","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1200\/JCO.1989.7.11.1693","article-title":"Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research","volume":"7","author":"Roila","year":"1989","journal-title":"J. Clin. Oncol."},{"issue":"31","key":"10.1016\/j.ctarc.2025.100938_bib0023","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: american Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2025.100938_bib0024","first-page":"161","article-title":"Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting","volume":"2","author":"Pater","year":"1994","journal-title":"Supp. Care Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2025.100938_bib0025","first-page":"807","article-title":"Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving Adriamycin-cyclophosphamide-based chemotherapy","volume":"19","author":"Warr","year":"2011","journal-title":"Supp. Care Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100938_bib0026","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/JCO.1997.15.1.116","article-title":"Determinants of post chemotherapy nausea and vomiting in patients with cancer. Quality of life and symptom control committees of the national cancer institute of Canada clinical trials group","volume":"15","author":"Osoba","year":"1997","journal-title":"J. Clin. Oncol"},{"issue":"9","key":"10.1016\/j.ctarc.2025.100938_bib0027","first-page":"1171","article-title":"Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two-phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy","volume":"18","author":"Hesketh","year":"2010","journal-title":"Supp. Care Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2025.100938_bib0028","first-page":"1549","article-title":"Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study","volume":"19","author":"Pirri","year":"2011","journal-title":"Supp. Care Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0029","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1634\/theoncologist.12-9-1143","article-title":"Guidelines for antiemetic treatment of chemotherapy induced nausea and vomiting: past, present, and future recommendations","volume":"12","author":"Jordan","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.ctarc.2025.100938_bib0030","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1200\/JCO.2006.06.9591","article-title":"American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006","volume":"24","author":"Kris","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0031","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/annonc\/mdj078","article-title":"Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia international antiemetic consensus conference","volume":"17","author":"Roila","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0032","series-title":"Treatment-related nausea and vomiting (PDQ)\u2014health professional version","author":"Supportive","year":"2017"},{"key":"10.1016\/j.ctarc.2025.100938_bib0033","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2025.100938_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/595894","article-title":"Treatment of breakthrough and refractory chemotherapy-induced nausea and vomiting","author":"Navari","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.ctarc.2025.100938_bib0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003495-200969050-00002","article-title":"Pharmacological management of chemotherapy-induced nausea and vomiting","volume":"69","author":"Navari","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ctarc.2025.100938_bib0036","first-page":"S391","article-title":"Overview of the prevention and management of CINV","volume":"24","author":"Natale","year":"2018","journal-title":"Am. J. Manag. Care"},{"issue":"8","key":"10.1016\/j.ctarc.2025.100938_bib0037","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/bjc.1997.507","article-title":"Patient perceptions of the side effects of chemotherapy: the influence of 5HT3 antagonists","volume":"76","author":"de Boer-Dennert","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2025.100938_bib0038","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2146\/ajhp160227","article-title":"New options and controversies in the management of chemotherapy-induced nausea and vomiting","volume":"74","author":"Koth","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ctarc.2025.100938_bib0039","doi-asserted-by":"crossref","unstructured":"Lee J., Dodd M., Dibble S., Abrams D. Review of acupressure studies for chemotherapy-induced nausea and vomiting control. J. Pain Symptom Manag. Novemb.; 2008 36(5): 529\u2013544. [PubMed: 18440769].","DOI":"10.1016\/j.jpainsymman.2007.10.019"},{"issue":"15s","key":"10.1016\/j.ctarc.2025.100938_bib0040","article-title":"Ginger for chemotherapy-related nausea in cancer patients: a URCC CCOP randomized, double-blind, placebo-controlled clinical trial of 644 cancer patients","volume":"27","author":"Ryan","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0041","article-title":"Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends","volume":"26","author":"Gupta","year":"2021","journal-title":"Cancer Treat. Res. Common."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100938_bib0042","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1471-4892(02)00227-8","article-title":"Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction","volume":"2","author":"Andrews","year":"2002","journal-title":"Curr. Opin. Pharmacol"},{"issue":"14","key":"10.1016\/j.ctarc.2025.100938_bib0043","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"7","key":"10.1016\/j.ctarc.2025.100938_bib0044","first-page":"1479","article-title":"Ginger (zingiber officinale) reduces acute chemotherapy induced nausea: a URCC CCOP study of 576 patients","volume":"20","author":"Ryan","year":"2012","journal-title":"Supp. Care Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100938_bib0045","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/pbc.22778","article-title":"Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy","volume":"56","author":"Pillai","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0046","doi-asserted-by":"crossref","DOI":"10.7314\/APJCP.2015.16.15.6207","article-title":"Prevention of chemotherap-induced nausea and vomiting in cancer patients","author":"Shankar","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ctarc.2025.100938_bib0047","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/annonc\/mdq194","article-title":"Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy- induced nausea and vomiting: results of the Perugia consensus conference","volume":"21","author":"Roila","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0048","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1200\/JCO.2015.64.3635","article-title":"Antiemetics: american Society of Clinical Oncology focused guideline update","volume":"34","author":"Hesketh","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0049","series-title":"Antiemesis, version 2","year":"2015"},{"key":"10.1016\/j.ctarc.2025.100938_bib0051","article-title":"Efficacy of auricular acupressure in prevention and treatment of chemotherapy- induced nausea and vomiting in patients with cancer: a systematic review and meta-analysis","author":"Chen","year":"2021","journal-title":"Evid.-Based Compl. Altern. Med."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100938_bib0052","first-page":"114","article-title":"Application of buried beans at auricular points in gastrointestinal reactions in patients undergoing cancer chemotherapy","volume":"42","author":"Pan","year":"2014","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.ctarc.2025.100938_bib0053","series-title":"PriceAromatherapy for health professionals","author":"S Price","year":"2007"},{"key":"10.1016\/j.ctarc.2025.100938_bib0054","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/foods8060185","article-title":"Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe)","volume":"8","author":"Mao","year":"2019","journal-title":"Foods"},{"key":"10.1016\/j.ctarc.2025.100938_bib0056","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1055\/s-0030-1270747","article-title":"Effects of ginger constituents on the gastrointestinal tract: role of cholinergic M3 and serotonergic 5-HT3 and 5-HT4 receptors","volume":"77","author":"Pertz","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.ctarc.2025.100938_bib0057","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejphar.2005.10.049","article-title":"Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum","volume":"530","author":"Abdel-Aziz","year":"2006","journal-title":"Eur. J. Pharm."},{"issue":"9","key":"10.1016\/j.ctarc.2025.100938_bib0058","first-page":"4031","article-title":"Music interventions for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis","volume":"28","author":"Wei","year":"2020","journal-title":"Supp. Care Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2025.100938_bib0059","first-page":"70","article-title":"Systematic evaluation of the effect of individualized music intervention on nausea and vomiting in cancer patients during chemotherapy","volume":"18","author":"Yixiao","year":"2020","journal-title":"Guide China Med."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100938_bib0060","first-page":"70","article-title":"Music therapy for relieving nausea and vomiting and improving quality of life in cancer patients after chemotherapy","volume":"24","author":"Jing","year":"2017","journal-title":"J. Nurs."},{"issue":"9","key":"10.1016\/j.ctarc.2025.100938_bib0061","first-page":"4051","article-title":"Progressive muscle relaxation is effective in preventing and alleviating of chemotherapy-induced nausea and vomiting among cancer patients: a systematic review of six randomized controlled trials","volume":"28","author":"Tian","year":"2020","journal-title":"Supp. Care Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2025.100938_bib0062","first-page":"16","article-title":"Professional committee of supportive care for oncology, Chinese expert consensus on prevention and treatment of nausea and vomiting associated with cancer drug therapy (2019 edition)","volume":"11","year":"2019","journal-title":"Chin. J. Front. Med. Sci. (Electron. Version)"},{"issue":"11","key":"10.1016\/j.ctarc.2025.100938_bib0063","first-page":"29","article-title":"Effect of relaxation training on cisplatin-induced acute and delayed nausea and vomiting in patients with lung cancer","volume":"31","author":"Dan","year":"2016","journal-title":"J. Nurs. Sci."},{"key":"10.1016\/j.ctarc.2025.100938_bib0064","first-page":"263","article-title":"Professional Committee of Cancer Rehabilitation and Palliative Care, Chinese Anti-Cancer Association; Expert Committee on Safety Management of Antineoplastic Drugs, Chinese Society of Clinical Oncology","volume":"3","year":"2014"},{"issue":"5","key":"10.1016\/j.ctarc.2025.100938_bib0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jand.2015.10.020","article-title":"Chemotherapy-induced nausea and vomiting: a narrative review to inform dietetics practice","volume":"116","author":"Marx","year":"2016","journal-title":"J. Acad. Nutr. Diet"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100938_bib0066","first-page":"128","article-title":"Meta-analysis on the effect of diet nursing on nausea and vomiting in patients undergoing cancer chemotherapy","volume":"37","author":"Tingyu","year":"2016","journal-title":"J. Mudanjiang Med. Coll."},{"issue":"9","key":"10.1016\/j.ctarc.2025.100938_bib0067","first-page":"1535","article-title":"Meta-analysis of the effect of Neiguan acupressure on improving chemotherapy induced nausea and vomiting in cancer patients","volume":"34","author":"Chen","year":"2020","journal-title":"Chin. Nurs. Res."},{"issue":"10","key":"10.1016\/j.ctarc.2025.100938_bib0068","first-page":"1604","article-title":"Clinical practice guidelines for acupuncture and moxibustion in the prevention and treatment of nausea after chemotherapy","volume":"16","author":"Yang","year":"2021","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0069","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4741193","article-title":"Evidence summary for nonpharmacological management of chemotherapy-induced nausea and vomiting","volume":"2022","author":"Li","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ctarc.2025.100938_bib0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fphar.2020.00329","article-title":"Patient-related risk factors for chemotherapy-induced nausea and vomiting: a systematic review","volume":"11","author":"Mosa","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0072","first-page":"303","article-title":"Experimental study on the effect of herb-separated moxibustion at Shenque point on gastrointestinal function in tumor-bearing chemotherapy rats","volume":"4","author":"Danhong","year":"1999","journal-title":"Acupunct. Res."},{"key":"10.1016\/j.ctarc.2025.100938_bib0073","first-page":"11","article-title":"Moxibustion for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis","volume":"2017","author":"Huang","year":"2017","journal-title":"Evid.-Based Compl. Altern. Med."},{"key":"10.1016\/j.ctarc.2025.100938_bib0074","first-page":"11","article-title":"Moxibustion for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis","volume":"2017","author":"Huang","year":"2017","journal-title":"Evid.-Based Compl. Altern. Med."},{"issue":"suppl 5","key":"10.1016\/j.ctarc.2025.100938_bib0075","first-page":"119","article-title":"MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients ann","volume":"27","author":"Roila","year":"2016","journal-title":"Oncology"},{"issue":"9","key":"10.1016\/j.ctarc.2025.100938_bib0076","first-page":"2833","article-title":"Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study","volume":"23","author":"Escobar","year":"2015","journal-title":"Supp. Care Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0077","series-title":"Oxford Handbook of Oncology","author":"Cassidy","year":"2011"},{"key":"10.1016\/j.ctarc.2025.100938_bib0078","series-title":"Clinical pharmacology","year":"2017"},{"key":"10.1016\/j.ctarc.2025.100938_bib0081","first-page":"45","article-title":"Akynzeo (netupitant and palonosetron), a dual-acting oral agent, approved by the FDA for prevention of chemotherapy-induced nausea and vomiting","volume":"8","author":"Raedler","year":"2015","journal-title":"Am. Health Drug Benefits"},{"key":"10.1016\/j.ctarc.2025.100938_bib0082","article-title":"Multinational Association of Supportive Care in Cancer","year":"2016","journal-title":"MASCC\/ESMO Antiemetic Guidel."},{"key":"10.1016\/j.ctarc.2025.100938_bib0083","series-title":"Antiemesis: clinical practice guidelines in oncology","year":"2017"},{"issue":"28","key":"10.1016\/j.ctarc.2025.100938_bib0084","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","article-title":"Antiemetics: american Society of Clinical Oncology clinical practice guideline update","volume":"35","author":"Hesketh","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0085","series-title":"Clinical pharmacology","year":"2017"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100938_bib0086","first-page":"7","article-title":"Prevention of chemotherapy-induced nausea and vomiting","volume":"39","author":"Khan","year":"2014","journal-title":"US Pharm."},{"issue":"5","key":"10.1016\/j.ctarc.2025.100938_bib0087","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003495-200969050-00002","article-title":"Pharmacological management of chemotherapy-induced nausea and vomiting","volume":"69","author":"Navari","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ctarc.2025.100938_bib0088","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40265-013-0019-1","article-title":"Management of chemotherapy-induced nausea and vomiting","volume":"73","author":"Navari","year":"2013","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.ctarc.2025.100938_bib0089","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/annonc\/mdq149","article-title":"Aprepitant: drug\u2013drug interactions in perspective","volume":"21","author":"Aapro","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2025.100938_bib0090","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2025.100938_bib0091","series-title":"Clinical pharmacology","year":"2017"},{"key":"10.1016\/j.ctarc.2025.100938_bib0092","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/annonc\/mdl019","article-title":"Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment","volume":"17","author":"Schmoll","year":"2006","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100938_bib0093","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1188\/09.CJON.54-64","article-title":"Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes","volume":"13","author":"Hawkins","year":"2009","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"12","key":"10.1016\/j.ctarc.2025.100938_bib0094","article-title":"Breast cancer patients' perceptions of their experience with chemotherapyinduced nausea and vomiting and its impact on quality of life in Jeddah, Saudi Arabia","volume":"12","author":"Ilyas","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ctarc.2025.100938_bib0095","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/search\/."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100938_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17521740701702115","article-title":"MEDLINE, PubMed, PubMed central, and the NLM","volume":"2","author":"Cross","year":"2006","journal-title":"Ed. Bull."},{"key":"10.1016\/j.ctarc.2025.100938_bib0011","series-title":"Common terminology criteria for adverse events (CTCAE) version 4.0","year":"2022"},{"key":"10.1016\/j.ctarc.2025.100938_bib0012","first-page":"229","article-title":"Prevention of cisplatin-induced delayed emesis: still unsatisfactory","volume":"8","year":"1999","journal-title":"Supp. Care Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0013","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/cncr.11408","article-title":"Nausea and emesis remain significant problems of chemotherapy despite pro phylaxis with 5-hydroxytryptamine-3 antiemetics","volume":"97","author":"Hickok","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0014","first-page":"368","article-title":"Chemotherapy induced nausea and vomiting in routine practice\u2014A European per spective [abstract]","volume":"10","author":"Glaus","year":"2002","journal-title":"Supp. Care Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0015","series-title":"Incidence of Chemotherapy-Induced Nausea and Emesis after Modern Antiemetics - Perception versus Reality","author":"Grunberg","year":"2004"},{"key":"10.1016\/j.ctarc.2025.100938_bib0016","first-page":"277","article-title":"Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians\u2019 and nurses\u2019 estimation vs. patients\u2019 reported outcomes","volume":"13","author":"Liau","year":"2005","journal-title":"Supp. Care Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.ctarc.2025.100938_bib0017","first-page":"5","article-title":"CINV: still troubling patients after all these years","volume":"26","author":"Aapro","year":"2018","journal-title":"Supp. Care Cancer"},{"key":"10.1016\/j.ctarc.2025.100938_bib0055","first-page":"1291","article-title":"Can nausea and vomiting be treated with ginger extract?","volume":"19","author":"Giacosa","year":"2015","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.ctarc.2025.100938_bib0071","series-title":"Meta-Analysis on Acupuncture Treatment of Chemotherapy Induced Nausea and Vomiting [D]","author":"Shan","year":"2020"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100938_bib0079","first-page":"7","article-title":"Prevention of chemotherapy-induced nausea and vomiting","volume":"39","author":"Khan","year":"2014","journal-title":"US Pharm."},{"key":"10.1016\/j.ctarc.2025.100938_bib0080","series-title":"Metoclopramide tablets. Package insert","year":"2016"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T21:14:24Z","timestamp":1756934064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":95,"alternative-id":["S2468294225000747"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100938","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systemic review on chemotherapy induced nausea and vomiting- risk and clinical management with alternative therapies","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100938"}}